Transpact Enterprises Ltd

Transpact Enterprises Limited was incorporated as a Private Limited Company with the name 'Transpact Enterprises Private Limited' on May 12, 2013. Further, the status of the Company was changed into Public Limited and the name of the Company was changed to 'Transpact Enterprises Limited' on April 16, 2019. The Company operates as a key player in India's capital markets, offering a comprehensive range of services including equity broking, investment advisory, portfolio management, and digital trading solutions. The primary business is dealing in shares, securities, commodities, currencies and their derivatives, Stock broker, Share broker, sub broker, authorized person, dealer, jobber, market maker, Investment brokers, Insurance broker, Underwriter, and to carry out brokerage of all and every kind whatsoever, portfolio manager, investment advisors, mutual funds, wealth management and other related services or any other business in any other manner. Their core business is to carry on the business of consulting and advisory services on all aspects of corporate, financial and commercial matters including management consulting, debt structuring, debt advisory, project appraisals, or any related items or things, required by any person, corporate, firm or association of persons and to undertake related services in India or abroad. The products include 'Vestibulator which is a compact, mechanized, innovative therapeutic healthcare device which is ergonomically designed to provide stimulations for vestibular, neuro- developmental and sensory integration therapy. Another product is 'Rehabsoft' which is a cloud-based therapy and rehabilitation software solution developed specifically to streamline and manage the therapy, rehab clinical documentation, nutrition schedule, administrative processes, and training and individual education plan. Apart from these, one more product includes 'Vestibulator Chair' which is an ergonomically-designed compact vestibular therapy device for at home therapy of children suffering from vestibular dysfunction and developmental disorders. The Company came up with a Public Issue by allotting 1,04,000 Equity Shares of face value of Rs 10 each and raised funds from public aggregating to Rs 1.35 Crore on 28 August, 2019.